Sökning: WFRF:(Miyamura Takako) >
Optimized cytogenet...
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
-
- van Weelderen, Romy E. (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
-
- Harrison, Christine J. (författare)
- Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom
-
- Klein, Kim (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
-
visa fler...
-
- Jiang, Yilin (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
-
- Abrahamsson, Jonas (författare)
- Department of Pediatrics, Institute of Clinical Sciences, Salgrenska University Hospital, Gothenburg, Sweden
-
- Alonzo, Todd (författare)
- Division of Biostatistics, University of Southern California, CA, Los Angeles, United States
-
- Aplenc, Richard (författare)
- Division of Oncology, Children's Hospital of Philadelphia, PA, Philadelphia, United States
-
- Arad-Cohen, Nira (författare)
- Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel
-
- Bart-Delabesse, Emmanuelle (författare)
- Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'Hématologie Secteur Génétique des Hémopathies, Toulouse, France
-
- Buldini, Barbara (författare)
- Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Department of Maternal and Child Health, Padua University, Padua, Italy
-
- De Moerloose, Barbara (författare)
- Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
-
- Dworzak, Michael N. (författare)
- Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, St. Anna Children's Cancer Research Institute, Vienna, Austria
-
- Elitzur, Sarah (författare)
- Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Tel Aviv University, Tel Aviv, Israel
-
- Fernández Navarro, José M. (författare)
- Department of Pediatric Oncohematology, Hospital Universitari i Politècnic la Fe, Valencia, Spain
-
- Gamis, Alan (författare)
- Department of Hematology and Oncology, Children's Mercy Hospital, MO, Kansas City, United States
-
- Gerbing, Robert B. (författare)
- Department of Statistics, Children's Oncology Group, CA, Monrovia, United States
-
- Goemans, Bianca F. (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
-
- de Groot-Kruseman, Hester A. (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; DCOG, Dutch Childhood Oncology Group, Utrecht, Netherlands
-
- Guest, Erin (författare)
- Department of Hematology and Oncology, Children's Mercy Hospital, MO, Kansas City, United States
-
- Ha, Shau-Yin (författare)
- Department of Pediatrics & Adolescent Medicine, Hong Kong Children's Hospital, Kowloon Bay, Hong Kong
-
- Hasle, Henrik (författare)
- Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
-
- Kelaidi, Charikleia (författare)
- Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece
-
- Lapillonne, Hélène (författare)
- Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France
-
- Leverger, Guy (författare)
- Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France
-
- Locatelli, Franco (författare)
- Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy
-
- Miyamura, Takako (författare)
- Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
-
- Norén-Nyström, Ulrika (författare)
- Umeå universitet,Pediatrik
-
- Polychronopoulou, Sophia (författare)
- Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece
-
- Rasche, Mareike (författare)
- Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
-
- Rubnitz, Jeffrey E. (författare)
- Department of Oncology, St. Jude Children's Research Hospital, TN, Memphis, United States
-
- Stary, Jan (författare)
- Department of Pediatric Hematology and Oncology, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic
-
- Tierens, Anne (författare)
- Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto General Hospital, ON, Toronto, Canada
-
- Tomizawa, Daisuke (författare)
- Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
-
- Zwaan, C. Michel (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, Netherlands
-
- Kaspers, Gertjan J.L. (författare)
- Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
-
visa färre...
-
(creator_code:org_t)
- American Society of Hematology, 2024
- 2024
- Engelska.
-
Ingår i: Blood Advances. - : American Society of Hematology. - 2473-9529 .- 2473-9537. ; 8:12, s. 3200-3213
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- A comprehensive international consensus on the cytogenetic risk-group stratification of KMT2A-rearranged (KMT2A-r) pediatric acute myeloid leukemia (AML) is lacking. This retrospective (2005-2016) International Berlin-Frankfurt-Münster Study Group study on 1256 children with KMT2A-r AML aims to validate the prognostic value of established recurring KMT2A fusions and additional cytogenetic aberrations (ACAs) and to define additional, recurring KMT2A fusions and ACAs, evaluating their prognostic relevance. Compared with our previous study, 3 additional, recurring KMT2A-r groups were defined: Xq24/KMT2A::SEPT6, 1p32/KMT2A::EPS15, and 17q12/t(11;17)(q23;q12). Across 13 KMT2A-r groups, 5-year event-free survival probabilities varied significantly (21.8%-76.2%; P < .01). ACAs occurred in 46.8% of 1200 patients with complete karyotypes, correlating with inferior overall survival (56.8% vs 67.9%; P < .01). Multivariable analyses confirmed independent associations of 4q21/KMT2A::AFF1, 6q27/KMT2A::AFDN, 10p12/KMT2A::MLLT10, 10p11.2/KMT2A::ABI1, and 19p13.3/KMT2A::MLLT1 with adverse outcomes, but not those of 1q21/KMT2A::MLLT11 and trisomy 19 with favorable and adverse outcomes, respectively. Newly identified ACAs with independent adverse prognoses were monosomy 10, trisomies 1, 6, 16, and X, add(12p), and del(9q). Among patients with 9p22/KMT2A::MLLT3, the independent association of French-American-British-type M5 with favorable outcomes was confirmed, and those of trisomy 6 and measurable residual disease at end of induction with adverse outcomes were identified. We provide evidence to incorporate 5 adverse-risk KMT2A fusions into the cytogenetic risk-group stratification of KMT2A-r pediatric AML, to revise the favorable-risk classification of 1q21/KMT2A::MLLT11 to intermediate risk, and to refine the risk-stratification of 9p22/KMT2A::MLLT3 AML. Future studies should validate the associations between the newly identified ACAs and outcomes and unravel the underlying biological pathogenesis of KMT2A fusions and ACAs.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
van Weelderen, R ...
-
Harrison, Christ ...
-
Klein, Kim
-
Jiang, Yilin
-
Abrahamsson, Jon ...
-
Alonzo, Todd
-
visa fler...
-
Aplenc, Richard
-
Arad-Cohen, Nira
-
Bart-Delabesse, ...
-
Buldini, Barbara
-
De Moerloose, Ba ...
-
Dworzak, Michael ...
-
Elitzur, Sarah
-
Fernández Navarr ...
-
Gamis, Alan
-
Gerbing, Robert ...
-
Goemans, Bianca ...
-
de Groot-Krusema ...
-
Guest, Erin
-
Ha, Shau-Yin
-
Hasle, Henrik
-
Kelaidi, Charikl ...
-
Lapillonne, Hélè ...
-
Leverger, Guy
-
Locatelli, Franc ...
-
Miyamura, Takako
-
Norén-Nyström, U ...
-
Polychronopoulou ...
-
Rasche, Mareike
-
Rubnitz, Jeffrey ...
-
Stary, Jan
-
Tierens, Anne
-
Tomizawa, Daisuk ...
-
Zwaan, C. Michel
-
Kaspers, Gertjan ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Blood Advances
- Av lärosätet
-
Umeå universitet